The Growth Investor Daily Brief
Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem. (0:00) Introduction and welcome (0:12) Series C+ funding highlights: Tractian, Tenstorrent, and Maze Therapeutics (3:19) Sponsor: Acme Corp (5:24) Wrap-up and closing remarks
9 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The Growth Investor Daily Brief community!